KLBF:IDX
Kalbe Farma Tbk PT
770,00Â IDR
arrow_upward
+0,65%(+5,00) 1 p
13. okt, 11:59:26 GMT +7 · IDR
search
Kõik sümbolid
| Sümbol | Hind | Muutus | % muutus |
|---|
insights_autoÜksuse KLBF põhistatistika genereerimine…
Ava
770Â IDR
Kõrge
775Â IDR
Madal
755Â IDR
Turu kapit.
36,05Â trln
Keskm. maht
66,50Â mln
Maht
11,93Â mln
Dividend
2,60%
Kvartaalne dividend
5Â IDR
Dividendikuupäev
4. juuni 2026
Hinna ja tulu suhe
9,68
52 näd kõrgeim
1Â 345Â IDR
52 näd madalaim
630Â IDR
Aktsiatulu
80Â IDR
Käibivad aktsiad
46,81Â mld
Töötajate arv
13Â tuh
Ava
770Â IDR
Kõrge
775Â IDR
Madal
755Â IDR
Turu kapit.
36,05Â trln
Keskm. maht
66,50Â mln
Maht
11,93Â mln
Dividend
2,60%
Kvartaalne dividend
5Â IDR
Dividendikuupäev
4. juuni 2026
Hinna ja tulu suhe
9,68
52 näd kõrgeim
1Â 345Â IDR
52 näd madalaim
630Â IDR
Aktsiatulu
80Â IDR
Käibivad aktsiad
46,81Â mld
Töötajate arv
13Â tuh
Uudised
Veebiallikatest ja uudistepartneritelt
The Daily News | Texas' Oldest Newspaper
·
1 tunni eest
A screen shows the logo and a ticker symbol for The Walt Disney Company on the floor of the New York Stock Exchange (NYSE) in New York
MarketBeat
·
5 minuti eest
Lendingclub (NASDAQ:HAPN) Shares Down 1.6% - Time to Sell?
TradingView
·
42 minuti eest
IXIC: Nasdaq Futures Shed 1% as Chip Selloff in Asia Triggers Trading Halt
Profiil
PT Kalbe Farma Tbk, or simply known as Kalbe, is an Indonesian pharmaceutical, healthcare and nutrition company established in 1966. The company has expanded by strategic acquisitions of pharmaceutical companies, becoming an integrated consumer health and nutrition enterprise.
The Kalbe Group has brands in the prescription drugs, OTC drugs, energy drink and nutrition products, with a distribution arm that reaches over one million outlets. Notably, the company produces misoprostol, a drug which is used to treat stomach ulcers but is also widely used in Indonesia as an illegal abortifacient.
Company brands in healthcare and pharmaceutical segments include Promag, Mixagrip, Woods, Komix, Diabetasol, Prenagen, Extra Joss and Fitbar.
Kalbe is the largest publicly listed pharmaceutical company in Southeast Asia with around US$5 billion in market capitalization and revenues of over Rp 15 trillion. The name "Kalbe" is a syllabic abbreviation of its founder's name: Khouw Lip Boen. Wikipedia
Teave üksuse Kalbe Farma Tbk PT kohta